Literature DB >> 35124746

Periodic quadriplegia during the acute postoperative phase of cervical laminoplasty: a case report and literature review.

Shinya Ueyama1, Sachio Hayama1, Masahiro Mizutani1, Yoshiharu Nakaya1, Yoshitada Usami1, Takashi Fujishiro2, Masashi Neo1.   

Abstract

The use of antibiotics can, in rare cases, induce neuromuscular blockade (NMB), resulting in paralytic symptoms. Although such antibiotic-induced NMB has been described in the anaesthesiology and infectious disease literature, it is an unfamiliar clinical entity in the fields of neurosurgery and spinal surgery. Herein, we report a case of periodic quadriplegia due to NMB induced by perioperative prophylactic antibiotic of cefazolin, resulting in highly confusing paralytic symptoms during the acute postoperative phase of cervical laminoplasty, together with a review of the relevant literature.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.

Entities:  

Keywords:  Cefazolin; Cervical laminoplasty; Complication; Epidural hematoma; Neuromuscular blockade; Perioperative prophylactic antibiotics

Mesh:

Substances:

Year:  2022        PMID: 35124746     DOI: 10.1007/s00701-022-05148-3

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  4 in total

1.  Perioperative anaphylaxis to cefazolin.

Authors:  Chyh-Woei Lee; Mariana C Castells
Journal:  Allergy Asthma Proc       Date:  2004 Jan-Feb       Impact factor: 2.587

2.  Neuromuscular blockade due to gentamicin sulfate.

Authors:  R J Brownsberger; H F Morrelli
Journal:  West J Med       Date:  1988-02

Review 3.  Antibiotic-induced paralysis.

Authors:  C B Pittinger; Y Eryasa; R Adamson
Journal:  Anesth Analg       Date:  1970 May-Jun       Impact factor: 5.108

4.  Neuromuscular blocking effects of tobramycin, gentamicin, and cefazolin.

Authors:  M Lippmann; E Yang; E Au; C Lee
Journal:  Anesth Analg       Date:  1982-09       Impact factor: 5.108

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.